Sign In
to Vote &
Create Storyboards.
 

Tocomin SupraBio® improves non-alcoholic fatty liver disease

Medical News Today - 28 Jan 2014 12:00
A ground-breaking human clinical study shows supplementation with patented and bioenhanced natural full spectrum palm tocotrienol complex (Tocomin SupraBio®) at 400mg daily for one year improves fatty liver in non-alcoholic fatty liver disease (NAFLD). NAFLD often coexists with metabolic syndrome especially type 2 diabetes and obesity. It is reported to be an independent risk factor for cardiovascular disease and affects approximately 30% of the population in Western countries.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard